Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for CV Sciences (CVSI) over the last 13 years, with Q3 2025 value amounting to $2.9 million.

  • CV Sciences' Accumulated Expenses fell 1601.4% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 1601.4%. This contributed to the annual value of $3.4 million for FY2024, which is 5.84% up from last year.
  • Latest data reveals that CV Sciences reported Accumulated Expenses of $2.9 million as of Q3 2025, which was down 1601.4% from $3.0 million recorded in Q2 2025.
  • Over the past 5 years, CV Sciences' Accumulated Expenses peaked at $10.9 million during Q4 2021, and registered a low of $500000.0 during Q1 2023.
  • Over the past 5 years, CV Sciences' median Accumulated Expenses value was $3.5 million (recorded in 2024), while the average stood at $5.9 million.
  • In the last 5 years, CV Sciences' Accumulated Expenses plummeted by 9513.43% in 2023 and then surged by 54960.0% in 2024.
  • Quarter analysis of 5 years shows CV Sciences' Accumulated Expenses stood at $10.9 million in 2021, then crashed by 38.62% to $6.7 million in 2022, then tumbled by 48.93% to $3.4 million in 2023, then increased by 0.06% to $3.4 million in 2024, then fell by 16.06% to $2.9 million in 2025.
  • Its Accumulated Expenses was $2.9 million in Q3 2025, compared to $3.0 million in Q2 2025 and $2.8 million in Q1 2025.